Literature DB >> 16308260

Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.

Chul-Ho Kim1, Sung-Kyun Moon, Joon-Ho Bae, Jae Ho Lee, Jae Ho Han, Kyubo Kim, Eun Chang Choi.   

Abstract

CONCLUSION: Our results suggest that hepatocyte growth factor (HGF) may play an important role in the progression of hypopharyngeal cancer.
OBJECTIVE: HGF, a potent stimulator of hepatocyte growth, stimulates the motility, invasiveness, proliferation and morphogenesis of epithelium and may be involved in physiologic and pathologic processes such as embryogenesis, wound healing, organ regeneration, inflammation and tumor invasion. We therefore examined the role of HGF and c-Met in the invasion and metastasis of hypopharyngeal squamous cell carcinoma (SCC).
MATERIAL AND METHODS: We performed immunohistochemical staining of 40 specimens each of normal mucosa and SCC of the hypopharynx with HGF and c-Met antibodies. For reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting, fresh normal and cancer tissue from the hypopharynx obtained from five patients were used.
RESULTS: Positive rates of HGF and c-Met expression in hypopharyngeal SCC were 77.5% and 70%, respectively. HGF staining was significantly correlated with lymph node metastasis and pathologic stage (p < 0.05). c-Met staining was only significantly correlated with lymph node metastasis (p < 0.05). Increased expression of c-Met mRNA (RT-PCR) and protein (Western blotting) was detected in hypopharyngeal cancer tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16308260     DOI: 10.1080/00016480510037014

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  16 in total

1.  Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.

Authors:  Yiru Xu; Jin Zhou; Thomas E Carey; Jonathan B McHugh; John J Voorhees; Gary J Fisher
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

2.  The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

Authors:  Tanguy Y Seiwert; Ramasamy Jagadeeswaran; Leonardo Faoro; Varalakshmi Janamanchi; Vidya Nallasura; Mohamed El Dinali; Soheil Yala; Rajani Kanteti; Ezra E W Cohen; Mark W Lingen; Leslie Martin; Soundararajan Krishnaswamy; Andres Klein-Szanto; James G Christensen; Everett E Vokes; Ravi Salgia
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

3.  HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.

Authors:  Lynn M Knowles; Laura P Stabile; Ann Marie Egloff; Mary E Rothstein; Sufi M Thomas; Christopher T Gubish; Edwina C Lerner; Raja R Seethala; Shinsuke Suzuki; Kelly M Quesnelle; Sarah Morgan; Robert L Ferris; Jennifer R Grandis; Jill M Siegfried
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

4.  Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.

Authors:  Shuang Li; Haiyang Zhang; Xinyi Wang; Yanjun Qu; Jingjing Duan; Rui Liu; Ting Deng; Tao Ning; Le Zhang; Ming Bai; Likun Zhou; Xia Wang; Shaohua Ge; Guoguang Ying; Yi Ba
Journal:  Tumour Biol       Date:  2016-09-28

5.  Prognostic value of c-Met expression in oral squamous cell carcinoma.

Authors:  Christian Freudlsperger; Dorothea Alexander; Siegmar Reinert; Juergen Hoffmann
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

6.  Prognostic role of c-met expression in breast cancer patients.

Authors:  Iwona Gisterek; Ewelina Lata; Agnieszka Halon; Rafal Matkowski; Jolanta Szelachowska; Przemyslaw Biecek; Jan Kornafel
Journal:  Rep Pract Oncol Radiother       Date:  2011-06-08

7.  Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma.

Authors:  Ji-Young Choe; Ji Yun Yun; Soo-Jeong Nam; Ji Eun Kim
Journal:  Korean J Pathol       Date:  2012-12-26

8.  Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma.

Authors:  Elyse L Walk; Scott A Weed
Journal:  Cancers (Basel)       Date:  2011-02-22       Impact factor: 6.639

9.  Role of met axis in head and neck cancer.

Authors:  Yiru Xu; Gary J Fisher
Journal:  Cancers (Basel)       Date:  2013-11-26       Impact factor: 6.639

10.  MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma.

Authors:  Ludovic Lacroix; Sophie F Post; Alexander Valent; Antoine E Melkane; Philippe Vielh; Coumaran Egile; Christelle Castell; Christelle Larois; Sandrine Micallef; Patrick Saulnier; Hélène Goulaouic; Anne-Marie Lefebvre; Stéphane Temam
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.